← Back to Search

MANAGE-VT Patients for Ventricular Tachycardia (MANAGE-VT Trial)

N/A
Recruiting
Research Sponsored by CorVita Science Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up july 20, 2020 - present
Awards & highlights

Summary

Data collection registry for patients with ventricular tachycardia to help physicians give better care for patients clinically and procedurally.

Eligible Conditions
  • Ventricular Tachycardia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~july 20, 2020 - present
This trial's timeline: 3 weeks for screening, Varies for treatment, and july 20, 2020 - present for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants with Risk of Sudden Cardiac Death
Prevent Risk of Stroke
Recurrence of Ventricular Tachycardia

Trial Design

1Treatment groups
Experimental Treatment
Group I: MANAGE-VT PatientsExperimental Treatment6 Interventions
Patients will be assessed on the status of their ventricular tachycardia as well as other criteria such as: EKG,
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ICD Implant
2005
N/A
~40
Antiarrhythmic drug
2017
Completed Phase 4
~730
Cardioversion
2017
N/A
~460
Echocardiogram
2016
Completed Phase 2
~1910

Find a Location

Who is running the clinical trial?

CorVita Science FoundationLead Sponsor
1 Previous Clinical Trials
1,000 Total Patients Enrolled
~76 spots leftby Jul 2030
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top